Pharma may face new fines under EU pharmacovigilance and paediatric regulations
This article was originally published in SRA
Executive Summary
The European Commission is planning to impose new financial penalties on drug companies if they fail to fulfil certain obligations under the EU Paediatric Regulation and the new pharmacovigilance legislation1,2.